from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3639c/-

LFCtreatmentdescriptionclass of inhibitor

-0.032

Amikacinug/mL Amikacintranslation

0.504

Cap5-10ug/mL Capreomycintranslation

-0.504

Rox10-50 ug/mL Roxithromycintranslation

-0.271

SM2-5 ug/mL Streptomycintranslation

1.256

Tet5-10 ug/mL Tetracyclinetranslation

-0.030

Rif0.2-5ug/mL Rifampicintranscription

0.081

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.687

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.395

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.066

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.627

Clofazimine10-13 ug/mL Clofaziminerespiration

1.030

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.465

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.869

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.310

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.225

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.422

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.078

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.114

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.782

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.672

KCN5-20 ug/mL Potassium cyaniderespiration

1.144

NaN30.2-2 mM Sodium aziderespiration

-0.090

Nigericin50 uM Nigericinrespiration

0.251

TRC10-150 ug/mL Triclosanrespiration

-0.050

TRZ10-25 ug/mL Thioridazinerespiration

1.004

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.766

menadione6-10 ug/mL Menadionerespiration

-0.308

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.288

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.041

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.372

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.459

NRP_1Non-replicating persistence stage 1dosRassociated

-0.487

Amp0.2mg/mL AmpicillincellWall

0.106

Cephalexin20-100 ug/mL CephalexincellWall

-0.898

Cerulenin0.32-5 ug/mL CerulenincellWall

0.927

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.249

EMB10-20 ug/mL EthambutolcellWall

-0.324

Eta12-40 ug/mL EthionamidecellWall

-0.090

INH0.2-0.4 ug/mL IsoniazidcellWall

0.029

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.304

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.387

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.259

BZA0.12 mg/mL BenzamidearomaticAmides

0.179

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.432

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.207

H2O24 mM hydrogen peroxideDNAdamaging

-0.516

Levo10 ug/mL LevofloxacinDNAdamaging

0.700

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.048

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.146

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.134

UVUV-irradiationDNAdamaging

0.704

ARP41-4 ug/mL Antitubercular compound ARP4?

0.363

Antimycin12.5-50 ug/mL Antimycin A?

0.045

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.101

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.773

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.137

PA8240.2-2 ug/mL PA-824?

-0.657

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-1.212

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.241

Verapamil50 uM Verapamil?

0.379

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.149

methoxatin10-20 ug/mL Methoxatin?